drugset / Trial / NCT04110587

Hyaluronic Acid Evaluation as Adjuvant to Temporomandibular Joint Arthroscopy

NCT04110587

RandomizedParallel-groupTriple-blindTreatment

Summary

This study evaluates the addition of hyaluronic acid to temporomandibular joint arthroscopy in the treatment of internal derangements in adults. A participants group will receive temporomandibular joint arthroscopy plus hyaluronic acid, while the other group will receive temporomandibular joint arthroscopy. Hypothesis: hyaluronic acid as an adjunct in temporomandibular joint arthroscopic surgery provides additional benefits in clinical and radiological outcomes in temporomandibular joint internal derangements.

Timeline

Start
2013-12-10
Primary completion
2019-07-09
Completion
2019-07-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hyaluronic Acid Other / unclassified 1 ml Other
Comparator Amoxicillin Other / unclassified 500 mg Intravenous
Comparator Dexamethasone Small molecule 4 mg Intravenous
Comparator Diclofenac Other / unclassified 100 mg Oral
Comparator clavulanic acid Small molecule 125 mg Intravenous
Comparator dipyrone Unknown 575 mg Oral